MENU
EYPT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

EyePoint Pharmaceuticals (EYPT) Ownership - Who owns EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals Inc is a pharmaceutical company... Show more

Profile

Industry
Pharmaceuticals Major
Address
480 Pleasant Street
Phone
+1 617 926-5000
Employees
121
Web
https://www.eyepointpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
708.23M
P/E Ratio
N/A
Total Cash
318.19M
Projected Growth
N/A
Total Debt
24.08M
Revenue
56.04M
Risk (Beta)
2.05
Dividend Yield
N/A
Total Cash/Share
4.62
Total Debt/Equity
N/A
Revenue/Share
0.80 USD as % of share price

Fundamentals

EYPT
Capitalization
708M
P/E Ratio
N/A
Risk (Beta)
2.05
Dividend Yield
N/A
Total Cash
318M
Total Cash/Share
4.62
Total Debt
24.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.80%
Revenue
56M
ROE
N/A
Book Value
298M
P/B Ratio
2.88
Cash Flow
N/A
Earnings
-2.42
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
69K
Current Ratio
7.85
Current Revenue Per Employee
81138.89
Dividends Per Share - Security
N/A
EBITDA
-144.55M
Float
N/A
Float - Current
N/A
Gross Income Margin
96.71
Revenue To Assets
-42.43
Shares Held By Institutions
623M
Shares Outstanding - Current
68.9M
Total Liabilities
64.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
37.919
View a ticker or compare two or three
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EYPT showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of ophthalmic pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
480 Pleasant Street
Phone
+1 617 926-5000
Employees
121
Web
https://www.eyepointpharma.com